MORELLI, EUGENIO
 Distribuzione geografica
Continente #
NA - Nord America 310
AS - Asia 140
EU - Europa 110
SA - Sud America 10
AF - Africa 5
OC - Oceania 1
Totale 576
Nazione #
US - Stati Uniti d'America 303
SG - Singapore 99
IT - Italia 50
DE - Germania 22
CN - Cina 19
GB - Regno Unito 11
IN - India 8
SE - Svezia 8
BR - Brasile 7
CA - Canada 6
FI - Finlandia 6
HK - Hong Kong 4
BD - Bangladesh 3
CZ - Repubblica Ceca 3
NL - Olanda 3
VN - Vietnam 3
EC - Ecuador 2
EG - Egitto 2
LT - Lituania 2
PK - Pakistan 2
AT - Austria 1
AU - Australia 1
ES - Italia 1
ET - Etiopia 1
IQ - Iraq 1
JP - Giappone 1
MX - Messico 1
NO - Norvegia 1
RU - Federazione Russa 1
TN - Tunisia 1
UA - Ucraina 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 576
Città #
Singapore 77
Chandler 72
Dallas 31
Munich 18
Santa Clara 16
Hefei 15
Lawrence 11
Princeton 11
Ashburn 10
Catanzaro 10
London 10
Milan 10
Chicago 9
New York 5
Turku 5
Hong Kong 4
Los Angeles 4
Montreal 4
Rome 4
Boardman 3
Charlotte 3
Olomouc 3
San Francisco 3
São Paulo 3
Wilmington 3
6th of October City 2
Ahmedabad 2
Bari 2
San Nicola Manfredi 2
Addis Ababa 1
Andover 1
Barueri 1
Basti 1
Biên Hòa 1
Bocale 1
Boston 1
Brooklyn 1
Chennai 1
Cincinnati 1
Council Bluffs 1
Da Nang 1
Dhaka 1
Duhok 1
Fayetteville 1
Graham 1
Greenville 1
Guangzhou 1
Hacienda Ibarra 1
Hanover 1
Helsinki 1
Ho Chi Minh City 1
Houston 1
Ipiaú 1
Itabira 1
Jacareí 1
Jaipur 1
Jhelum 1
Jinhua 1
Kollam 1
La Marsa 1
Lucknow 1
Melbourne 1
Messina 1
Mexico City 1
Mountain View 1
Naples 1
Novokuznetsk 1
Nuremberg 1
Ottawa 1
Peshawar 1
Portland 1
Quito 1
Redmond 1
San Mateo 1
Stockholm 1
Tallahassee 1
Tokyo 1
Torino 1
Upington 1
Uppsala 1
Valencia 1
Vienna 1
Totale 405
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 90
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 52
In Vitro Silencing of lncRNAs Using LNA GapmeRs 47
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 46
Inhibitor of DNA binding 2 (ID2) regulates key transcriptional programs in multiple myeloma 43
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network 43
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 38
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 38
JunB is a key regulator of multiple myeloma bone marrow angiogenesis 38
The non-coding RNA landscape of plasma cell dyscrasias 37
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 35
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 32
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 23
Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesis (Leukemia, (2021), 35, 12, (3509-3525), 10.1038/s41375-021-01271-9) 23
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 12
Totale 597
Categoria #
all - tutte 6.388
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.388


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 1 0 0 1 0 0 1 0 0
2021/202235 1 0 0 6 0 0 6 4 9 4 3 2
2022/2023164 23 15 11 5 22 13 0 21 29 12 10 3
2023/202471 15 15 3 10 2 14 3 1 1 0 1 6
2024/2025197 21 5 10 15 13 40 8 6 6 2 27 44
2025/2026107 32 40 34 1 0 0 0 0 0 0 0 0
Totale 597